Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
about
Endocrine neoplasms in familial syndromes of hyperparathyroidismManagement of pancreatic neuroendocrine tumors in patients with MEN 1Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword?Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.Multiple Endocrine Neoplasia: Genetics and Clinical Management.MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsPreliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patientsAn unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 geneENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Zollinger-Ellison syndrome: recent advances and controversies.The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up.Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patientsMultiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Pathophysiology of Gastric NETs: Role of Gastrin and Menin.Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies.Novel mutation 928G>C of MEN1 gene in a familial multiple endocrine neoplasia type 1 case (MEN1) with co-existence of insulinoma and glucagonoma.Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.The future: genetics advances in MEN1 therapeutic approaches and management strategies.The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumours?Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours.Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome.Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
P2860
Q26747174-753DBC4E-D14F-41E3-874A-63F6897EB6BBQ27000026-EE231AB9-420E-4268-B15C-AA57FE0514A8Q30491060-EF38BB75-C478-4EF2-A27F-F513C69B1DDCQ33656493-1C4F910E-A6F7-488D-B2E9-43A7970AC0BBQ35891227-C23A5DD5-DC38-46A7-9AC9-A1667BD291D6Q36063577-05FEAAD5-327F-46B7-BE3C-C7067CB0C777Q36192096-42850A1C-A7BA-412E-8D15-57D9BD502428Q36770359-AA874E7B-5F35-49D8-928F-C803D39F3979Q36790777-E5044F32-3D60-444F-A920-40430F2D842BQ36849357-5710DB61-A010-4184-83A7-2EFA3B4DDB00Q38150165-F9D455FE-72D1-420C-9F43-5C24DB55054AQ38358391-C820924F-A2BB-4F33-87CE-AB1C1A0B7339Q38827497-3059518F-53E3-404C-9D14-8BA8FE6B0969Q38852179-C43B4DD7-223B-4FC0-8C40-12CBB7A201A7Q38951675-D84AC839-3D48-4814-BEC6-577ED7C9A5ABQ38956091-A23FCE32-8751-400A-8E6C-DDBC6954755BQ39368598-D60290D4-B0F6-4990-824C-A0819E0A49E7Q43066318-AEAAF4B0-8A1E-419E-81C4-1FC3D5AE359AQ44912147-A5CB6EB7-3557-4BF9-9665-A0F0DA1128E0Q45062413-AE7B6F74-59EA-457D-B416-8593D94D749DQ47630399-05C18CE7-9667-45E4-8095-10D1FFD3D20EQ47814736-34FB9178-E2EE-4862-9D6D-C1F1F9D28BCBQ47822235-300A70E7-B84B-4526-B4D5-DD10140EFDC0Q47913061-91FDD511-F62B-46C6-B548-BA0E30FA0F72Q48961547-03C7E818-C12E-4865-BEE1-CECC6C502438Q49165538-F47EB1E7-9D7E-461B-AFC1-F11BF1C99814Q49303197-D861E28A-40BA-4DBF-88CD-BB6DD1F8DA3CQ50075239-3D6FC7D7-BCA5-4335-B597-F8C7DAB5BBD7Q50165928-F08C70A4-F075-4A5C-8919-C5BF2ECD35F9Q54638848-EAFEB7C8-29C4-4BBB-AF9D-B7F9FC9D2141
P2860
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@en
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@nl
type
label
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@en
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@nl
prefLabel
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@en
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@nl
P2093
P2860
P1433
P1476
Causes of death and prognostic ...... t pancreatic endocrine tumors.
@en
P2093
Hirotsugu Uehara
Hisato Igarashi
Marc J Berna
Robert T Jensen
Tetsuhide Ito
P2860
P304
P356
10.1097/MD.0B013E3182954AF1
P407
P577
2013-05-01T00:00:00Z